Synlogic Inc. (NASDAQ:SYBX) changes shares on Monday trading session, with a change of 0.00% or $0.0 shares. The trading starts at $2.18 and closed at $2.16 throughout the day. The trading session low price was $2.0998 and day high was $2.20 on Monday, June 22. After the session, the Healthcare sector daily volume shifted to 0.24 million while its average volume is 286.48K. In other hand, the SYBX market cap reached to $69.60M. While, its current target price is $2.16 according to WSJ.
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -3.14% and down -3.57% for month. Its quarterly performance was 13.09% above, while its half year performance is down -2.26%. SYBX yearly performance stood at negative -76.97% and fall -16.28% for year-to-date. Current recommendation for Synlogic Inc. is 2.00.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. SYBX EPS (TTM) for 12-month is -1.68. EPS for this year is 16.40%, while for the next year its value is -1.68. Its EPS Q/Q reached 9.70%. It has an EPS of 23.60% up for past five years.
Let’s take a look on the analyst recommendations on SYBX for the current month and previous month. For the current month, 7 of 9 analysts recommend stock as Buy while 1 as Sell, 0 as overweight, 0 as underweight and 1 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $2.00-$13.00. Average target price for SYBX was reached at $7.25.
NEA Management Company, LLC, Atlas Venture Associates IX, LLC and Orbimed Advisors LLC. are the top three holders in Synlogic Inc. (SYBX) stock. On Mar 30, 2020, NEA Management Company, LLC has 4.23 million shares which valued 7.27 million. On Mar 30, 2020, Atlas Venture Associates IX, LLC owned 2.65 million shares which valued at 4.56 million. On Mar 30, 2020, Orbimed Advisors LLC. has a total of 2.03 million shares which valued at 3.49 million. In the end, Orbimed Advisors LLC. have 6.18% shares outstanding of Synlogic Inc. (SYBX) on Mar 30, 2020. The insider ownership moved to 0.40% and institutional holding shifted to 50.20%.
The company posted an EPS (TTM) of -1.68. According to the most recent quarter report on (Jun 2020), 9 analysts estimated an average EPS of -0.46, while -0.45 EPS posted a year ago period. Analyst Estimated EPS for SYBX published in the report was -0.52–0.43 during the same period. Comparing with last year, the average estimated EPS was -0.45 which is higher than -0.46 which was posted for recent quarter EPS.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for SYBX fall -4.83% for period of 200 days. SMA for 50 days was -1.47% which is showing red signal, while SMA-20 was -6.17%. The moving average value for Synlogic Inc. (SYBX) is 2.2756 and 2.2617 for 200 and 50 days respectively.
Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in SYBX stock. On Dec 13, Shea Richard P, Director, bought 7,500 trading shares at the cost of $2.74, which valued at 20550.0.